Our Stories

Risk more than doubled when hemoglobin A1C levels increased from 5.0% to 5.7%, a range typically considered normal or healthy A well-established marker of diabetes may signify heightened risk of...

Researchers from Quest Diagnostics presented original research on Alzheimer’s disease (AD), based on Quest’s AD-Detect® suite of blood-based biomarker (BBM) testing, at two leading...

Despite widely available lab tests and curative treatment, hepatitis C virus (HCV) remains one of the most common blood-borne infections in the United States. Researchers from Quest Diagnostics,...

In June, researchers from Quest Diagnostics published findings of a national study in The Journal of Clinical Endocrinology and Metabolism (JCEM), the leading clinical journal of the Endocrine...

Experts from Quest Diagnostics will highlight data from 13 studies on a range of laboratory topics at the 2026 Association for Diagnostics & Laboratory Medicine’s (ADLM) Annual Meeting, July 26-30,

Quest Diagnostics presented research results at the American Diabetes Association’s 2026 Scientific Sessions, which occurred in New Orleans on June 5-8. The study, presented as a poster, was...

In March, the American Heart Association (AHA), along with other leading medical associations, issued updated guidelines focused on early intervention and reducing risk of cardiovascular disease....

Nearly three million individuals worldwide live with a diagnosis of multiple sclerosis (MS), a chronic autoimmune disease. Evidence suggests that both incidence and prevalence rates of MS have...

Up to 16% of individuals with normal low-density lipid (LDL) cholesterol levels may have dangerous lipid particles that put them at risk of adverse cardiovascular events, including a heart attack...